Latest News & Features
Americas
US-based Heritage Pharmaceuticals has warned customers that a counterfeit of a brain cancer treatment drug it owns is being sold abroad. 12 May 2016
Big Pharma
There is a lack of judicial guidance in Europe on the issue of third party supplementary protection certificates (SPCs), otherwise known as “SPC squatting”, as Trevor Cook of WilmerHale explains. 12 May 2016
Big Pharma
The Association of the British Pharmaceutical Industry and the BioIndustry Association have said they want the UK to remain in Europe. 11 May 2016
Asia-Pacific
Gilead has been granted a patent for its hepatitis C drug Sovaldi in India, despite concerns over the cost of the drug. 10 May 2016
Americas
Pharmaceutical company Sanofi has failed to transfer the domain name sanofi.xin, despite the fact it has a registered trademark for exactly the same term. 9 May 2016
Americas
The US Federal Trade Commission has approved a final order settling charges that pharmaceutical company Hikma’s buyout of Roxane Laboratories and Boehringer Ingelheim Roxane would be anticompetitive. 6 May 2016
Americas
AstraZeneca has completed its acquisition of pharmaceutical company Takeda’s respiratory business. 5 May 2016
Americas
Pharmaceutical company Allergan has received approval from the US Food and Drug Administration to launch a generic version of a cholesterol drug owned by AstraZeneca. 5 May 2016
Americas
CRISPR is only part of the gene editing story, and by studying the patents associated with all of the various methods, a much clearer picture of the entire field can be generated, says Tony Trippe, senior patent analyst for Thomson Reuters. 5 May 2016
Big Pharma
Law firm Cooley has hired Colm Murphy as a partner in the firm’s life sciences patent counselling and prosecution practice in London. 4 May 2016